In the past week, XRTX stock has gone up by 3.89%, with a monthly gain of 0.54% and a quarterly surge of 2.75%. The volatility ratio for the week is 21.32%, and the volatility levels for the last 30 days are 13.04% for XORTX Therapeutics Inc The simple moving average for the past 20 days is 14.68% for XRTX’s stock, with a -23.40% simple moving average for the past 200 days.
Is It Worth Investing in XORTX Therapeutics Inc (NASDAQ: XRTX) Right Now?
Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for XRTX is 2.69M, and currently, shorts hold a 1.16% of that float. The average trading volume for XRTX on October 16, 2024 was 2.78M shares.
XRTX) stock’s latest price update
The stock price of XORTX Therapeutics Inc (NASDAQ: XRTX) has surged by 23.03 when compared to previous closing price of 1.52, but the company has seen a 3.89% gain in its stock price over the last five trading sessions. globenewswire.com reported 2024-10-09 that Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism
XRTX Trading at 12.53% from the 50-Day Moving Average
After a stumble in the market that brought XRTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -75.15% of loss for the given period.
Volatility was left at 13.04%, however, over the last 30 days, the volatility rate increased by 21.32%, as shares surge +6.86% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +19.11% upper at present.
During the last 5 trading sessions, XRTX rose by +3.89%, which changed the moving average for the period of 200-days by -14.22% in comparison to the 20-day moving average, which settled at $1.6306. In addition, XORTX Therapeutics Inc saw -19.05% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for XRTX
The total capital return value is set at -1.84. Equity return is now at value -29.36, with -23.54 for asset returns.
Based on XORTX Therapeutics Inc (XRTX), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -53.08.
Currently, EBITDA for the company is -6.47 million with net debt to EBITDA at 0.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.58.
Conclusion
In conclusion, XORTX Therapeutics Inc (XRTX) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
